Eric F. Egelund, Ph.D., Pharm.D.

Eric F. Egelund

Clinical Assistant Professor

Pharmacotherapy and Translational Research

OFFICE: 580 W. 8th Street

EMAIL: eegelund@ufl.edu

PHONE: 904-244-9876

CV: Link to CV

 

Education

  • Ph.D., University of Florida
  • Pharm.D., University of Florida
  • B.S. in Microbiology, University of West Florida

Biographical Sketch

After completing his Pharm.D. at the University of Florida College of Pharmacy, Dr. Egelund enrolled in the Ph.D. program at the University of Florida. Dr. Egelund completed his graduate studies in the Department of Pharmacotherapy and Translational Research under the mentorship of Dr. Charles Peloquin, director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) in Gainesville. Currently Dr. Egelund is a Clinical Assistant Professor at the College of Pharmacy’s Jacksonville campus. In addition to this role Dr. Egelund works part-time at Walgreens and volunteers at HIV clinics when time permits.

Research Interests

Dr. Egelund’s primary research interest is the pharmacokinetics of infectious disease agents, specifically those used for the treatment of tuberculosis, non-tuberculosis mycobacteria (NTM), and HIV.  Additionally, Dr. Egelund has an interest in interprofessional education, in particular, utilizing simulations to prevent medication errors.​

Affiliations

Florida Pharmacy Association
American College of Clinical Pharmacy
American Academy of HIV Medicine
Making a Difference in Infectious Disease
American Society of Microbiology
Society for Simulation in Healthcare
American Society of Pharmacovigilance

Publications

Egelund EF, Casapao AC.  Pet Nemo’s Pills—The last loophole in antimicrobial stewardship?  Clinical Infectious Diseases.  May 2019.

Brooks KM, Sherman E, Egelund EF, Brotherton A, Durham S, Badowski M, Cluck DB.  Integrase Inhibitors – 10 years of experience, is the best yet to come? Pharmacotherapy. March 2019.

Morrisey T, Genuardi F, Gannon J, Motcyka CM, Egelund EF.  Interprofessional Collaboration in Health Science Education.  Northeast Florida Medicine. December 2018.

Childs-Kean LM, Egelund EF, Jourjy J.  Tenofovir alafenamide (TAF) for the treatment of chronic hepatitis B mono-infection.  Pharmacotherapy.  August 2018.

Egelund EF, Gannon J, Motycka CM, Smith WT, Kraemer D, Solomon K.  A Simulated Approach to Fostering Competence in End-of-Life care Among Pharmacy Students. American Journal of Pharmacy Education. July 2018 ​